Healthcare Global Enterprises Li (NSE: HCG) and Paras Healthcare Ltd (NSE: PARASHLTH) are both listed in the Hospitals and Healthcare Centers industry. Healthcare Global Enterprises Li has a market capitalisation of ₹8,761 Cr and Paras Healthcare ₹7,999 Cr, as of 9 Nov 2026. Their P/E ratios are 611.3 and 170.3 respectively.
| Metric | Healthcare Global Enterprises Li | Paras Healthcare |
|---|---|---|
| NSE Symbol | HCG | PARASHLTH |
| BSE Code | 539787 | 545005 |
| Share Price | ₹587.10 | ₹752.00 |
| Market Cap | ₹8,761 Cr | ₹7,999 Cr |
| P/E Ratio | 611.3 | 170.3 |
| Return on Equity | 1.90% | — |
| Return on Assets | 3.81% | 18.20% |
| Beta (1Y) | 0.35 | — |
| 1-Year Price Change | -22.0% | — |
| 3-Month Price Change | -18.0% | — |
| 52-Week Range | ₹513.30 – ₹775.00 | ₹706.00 – ₹794.40 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹732 Cr | ₹511 Cr |
| Quarterly Net Profit | ₹9 Cr | ₹40 Cr |
| Net Margin | 1.3% | 7.9% |
| EPS (Basic, Quarter) | ₹0.32 | ₹4.00 |
| Results Basis | consolidated | consolidated |
| Headquarters | Bengaluru, Karnataka | Gurugram, Haryana |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marro…
Paras Healthcare Limited provides tertiary and quaternary healthcare services. The company provides cardiac sciences, neurosciences, oncology sciences, gastro sciences, orthopedics and sports injury, and renal sciences services. It offers services, such as cardio thoracic vascular surgery and cardiology; medical, radiation, surgical, and hemato oncology, as well as nuclear medicine and bone marrow transplant; and neuroscience, neuro intervention, neurology, and spine surgery. The company also provides gastrointestinal surgery, gastroenterology, and liver transplant; nephrology, urology, and ki…
Healthcare Global Enterprises Li has a market capitalisation of ₹8,761 Cr, against ₹7,999 Cr for Paras Healthcare as of 9 Nov 2026, so the two are about the same size by market cap.
Healthcare Global Enterprises Li has a P/E of 611.3 and Paras Healthcare a P/E of 170.3 as of 9 Nov 2026.
Healthcare Global Enterprises Li reported revenue of ₹732 Cr and net profit of ₹9 Cr for Q2 FY27. Paras Healthcare reported revenue of ₹511 Cr and net profit of ₹40 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.